On the role of digital tools in nitrosamine risk assessment for drug substance and drug product manufacturing processes

被引:1
|
作者
Eren, Ayse [1 ]
Moon, David [2 ]
Curran, Timothy [3 ]
Luciani, Carla [1 ]
机构
[1] Vertex Pharmaceut, Pharmaceut Sci Engn & Mat Sci, 50 Northern Ave, Boston, MA 02210 USA
[2] Vertex Pharmaceut, Pharmaceut Sci Analyt Dev, 50 Northern Ave, Boston, MA 02210 USA
[3] Vertex Pharmaceut, Pharmaceut Sci Proc Chem, 50 Northern Ave, Boston, MA 02210 USA
关键词
N-NITROSAMINES; KINETICS; DECOMPOSITION;
D O I
10.1016/j.coche.2024.101030
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nitrosamine risk assessments are useful to identify processes and/or materials that exhibit legitimate safety concerns to evaluate appropriate actions and controls. Fundamental understanding of nitrosamine toxicity, formation pathways, fate, and purge aid risk quantification. In this work, available digital tools to aid nitrosamine risk assessments are reviewed. From structure-activity relationships through kinetic models to purge factors, these tools can shed light on the various aspects of a nitrosamine risk assessment. While tremendous progress has been made over the last few years, industry, academia, and government still need to focus on supporting science-based decisions and the integration of diverse tools to provide a holistic view of the nitrosamine risk.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Prediction of N-Nitrosamine Partition Coefficients for Derisking Drug Substance Manufacturing Processes
    Ashworth, Ian W.
    Curran, Timothy T.
    Ford, J. Gair
    Tomasi, Simone
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2021, 25 (04) : 871 - 883
  • [2] Prediction of N-Nitrosamine Partition Coefficients for Derisking Drug Substance Manufacturing Processes
    Ashworth, Ian W.
    Curran, Timothy T.
    Ford, J. Gair
    Tomasi, Simone
    Organic Process Research and Development, 2021, 25 (04): : 871 - 883
  • [3] An Overview of Drug Substance Manufacturing Processes
    Noah J. Wichrowski
    Adam C. Fisher
    Nilou S. Arden
    Xiaochuan Yang
    AAPS PharmSciTech, 21
  • [4] An Overview of Drug Substance Manufacturing Processes
    Wichrowski, Noah J.
    Fisher, Adam C.
    Arden, Nilou S.
    Yang, Xiaochuan
    AAPS PHARMSCITECH, 2020, 21 (07)
  • [5] On the Risk of Nitrosamine Contamination During Drug Product Blister Packaging
    Zheng, Jinjian
    Brookes, Andrew
    Moser, Justin
    Pfeffer, Harvey
    Smith, Andrew
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (09) : 2321 - 2325
  • [6] The assessment of impurities for genotoxic potential and subsequent control in drug substance and drug product
    Dow, Linda K.
    Hansen, Marvin M.
    Pack, Brian W.
    Page, Todd J.
    Baertschi, Steven W.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (05) : 1404 - 1418
  • [7] Reflections on the Impact of Nitrosamine Drug Substance Related Impurities
    Teasdale, Andrew
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2023, 27 (10) : 1685 - 1686
  • [8] Nitrite in Pharmaceutical Manufacturing Water: Development of an Ultra-Sensitive Analytical Method, Typical Data, and Discussion of Potential Nitrosamine Formation in Drug Substance and Drug Product from Water
    Suresh Kumar, A. B.
    Dey, Debasis
    Balaji, T. S.
    Karthik, Haridoss
    Sathishkumar, K.
    Mcdaid, Paul
    Fitzpatrick, Brian
    Awasthi, Atul
    Davies, Simon
    Dirat, Olivier
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2024, 28 (07) : 2614 - 2622
  • [9] Dissecting contributors to particle formation in drug product sourced from alternative drug substance processes
    Goss, Monica Pallitto
    Jiang, Ge
    Gholdston, Merleen
    Ko, Jason
    Kitchen, Neil
    Crowell, Chris
    McNerney, Thomas
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [10] CHEMICAL SUBSTANCE AND DRUG PRODUCT
    MARCUS, AD
    AMERICAN JOURNAL OF PHARMACY, 1969, 141 (01): : 28 - &